Fri 15 Dec 2023 Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C. | Press Release Zuidland, The Netherlands, | Dec. 15, 2023...
Tue 7 Nov 2023 CERIOS by DORC: introduction tour | Research and Innovation Meet the CERIOS (Center of Expertise, Research and Innovation in Ophthalmic Surgery) project team, your knowledgeable guides for a brief tour of our brand new ...
Wed 1 Nov 2023 DORC has been awarded the EcoVadis Bronze Medal | ESG DORC has been awarded the EcoVadis Bronze Medal, recognizing our steadfast dedication to sustainability and responsible business practices....
Fri 15 Sep 2023 DORC announces the opening of CERIOS | Research and Innovation Fueled by our shared commitment to restoring patients' vision, collaborative innovation with our surgeon partners has always been a fundamental corners...
Mon 24 Jul 2023 DORC confirms that the FDA has granted DORC’s Orphan-Drug Designation application for trypan blue and brilliant blue G to selectively stain the internal limiting and epiretinal membrane | Press Release Exeter, NH – DORC is proud to announce that it has received notification from the U.S....
Fri 16 Jun 2023 DORC40: special video series | Testimonials This year DORC is celebrating a remarkable milestone - our 40th anniversary!...
Wed 30 Nov 2022 DORC Cairo Retina Meeting Symposium | INVITATION Planning to attend Cairo Retina Meeting in January?...
Mon 28 Nov 2022 DORC at FLORetina: Satellite Meeting, Live Surgeries and Innovation Lab | INVITATION Dear surgeons attending FLORetina congress in Rome, welcome to DORC booth and DORC Innovation Lab!...
Fri 14 Oct 2022 DORC acquires 100% of the shares in Peregrine Surgical LLC and completes the acquisition of the remaining stake in WEFIS GmbH | PRESS RELEASE Zuidland, NETHERLANDS – DORC International announced today the acquisition of Peregrine Surgical LLC and the acquisition of the full ownership of WEFIS...